U.S. House of Representatives

An appropriations bill from a committee in the U.S. House of Representatives would direct the FDA to unify its food program under one person.

The move echoes the sentiment from a House committee, former FDA leaders, and experts in the field of food safety.

In recent years members of the

Continue Reading House committee directs FDA Commissioner to unify FDA food programs with a clear chain of command

The chairman of a U.S. House subcommittee has demanded that the FDA provide Congress with an explanation of why it took so long to deal with an ongoing outbreak linked to infant formula.

Democratic Rep. Raja Krishnamoorthi, chairman of the House Subcommittee on Economic and Consumer Policy, sent a letter
Continue Reading Representative demands answers from FDA about outbreak linked to infant formula

Opinion

Editor’s note: For news about the congressional report, please click here.

The FDA takes exposure to toxic elements in the food supply extremely seriously, especially when it comes to protecting the health and safety of the youngest and most vulnerable in the population. Toxic elements, such as arsenic
Continue Reading FDA responds to questions about report on lead, other toxins in baby food

A new congressional report has revealed highly dangerous levels of arsenic and other poisons in baby food. It also reveals that Walmart, Campbell Foods, and Sprout Organic Foods refused to cooperate with the subcommittee’s investigation.

“Nurture, Beech-Nut, Hain and Gerber cooperated with the subcommittee’s investigation, despite the fact that doing
Continue Reading New report says arsenic, other metals consistently contaminate baby foods

The U.S. House of Representatives has unanimously passed the FASTER Act, bringing sesame one step closer to becoming the ninth major allergen, as defined by federal law.

The Act would also require the federal government to analyze research opportunities to help develop more effective treatments for food allergies.

The legislation,
Continue Reading U.S. House of Representatives unanimously passes FASTER Act

The Alliance for a Stronger FDA — which unites consumers, patient groups and industry in advocating for Food and Drug Administration (FDA) funding — Wednesday thanked the U.S. House appropriators for moving legislation forward that would provide a significant funding increase for the FDA.

The added funds would enable FDA
Continue Reading House bill would boost FDA funding to more than $300 million